On Tuesday, Twist Bioscience Corp (NASDAQ: TWST) was 2.31% jump from the session before ,before settling in for the closing price of $32.97. A 52-week range for TWST has been $11.46 – $43.21.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 60.13% over the past five years. When this article was written, the company’s average yearly earnings per share was at 14.54%. With a float of $55.30 million, this company’s outstanding shares have now reached $57.56 million.
Let’s look at the performance matrix of the company that is accounted for 919 employees.
Twist Bioscience Corp (TWST) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Twist Bioscience Corp stocks. The insider ownership of Twist Bioscience Corp is 4.36%, while institutional ownership is 108.70%. The most recent insider transaction that took place on Apr 02 ’24, was worth 37,057. In this transaction Chief Executive Officer of this company sold 1,132 shares at a rate of $32.74, taking the stock ownership to the 514,149 shares. Before that another transaction happened on Apr 02 ’24, when Company’s President and COO sold 492 for $32.74, making the entire transaction worth $16,106. This insider now owns 178,380 shares in total.
Twist Bioscience Corp (TWST) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/30/2023, it has been observed that the corporation posted -$0.75 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.78) by $0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.54% per share during the next fiscal year.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
You can see what Twist Bioscience Corp (TWST) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.60, a number that is poised to hit -0.81 in the next quarter and is forecasted to reach -2.67 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Twist Bioscience Corp (NASDAQ: TWST) saw its 5-day average volume 0.63 million, a negative change from its year-to-date volume of 0.93 million. As of the previous 9 days, the stock’s Stochastic %D was 47.59%. Additionally, its Average True Range was 1.79.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 61.49%, which indicates a significant increase from 44.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.91% in the past 14 days, which was lower than the 74.12% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $36.29, while its 200-day Moving Average is $26.94. Nevertheless, the first resistance level for the watch stands at $34.08 in the near term. At $34.44, the stock is likely to face the second major resistance level. The third major resistance level sits at $35.04. If the price goes on to break the first support level at $33.12, it is likely to go to the next support level at $32.52. The third support level lies at $32.16 if the price breaches the second support level.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
There are 57,818K outstanding shares of the company, which has a market capitalization of 1.95 billion. As of now, sales total 245,110 K while income totals -204,620 K. Its latest quarter income was 71,500 K while its last quarter net income were -43,010 K.
